Inflammatory bowel disease (IBD) and low-grade intestinal lymphoma are among the most difficult differential diagnoses in veterinary medicine — especially in cats. Both cause chronic vomiting, diarrhea, weight loss, and loss of appetite, and typically occur in middle-aged and older animals. Accurate diagnosis is critical, as treatments differ significantly: IBD is treated with immunosuppression, lymphoma with chemotherapy.
Why Differentiation Is So Difficult
Severe lymphocytic-plasmacytic IBD and low-grade lymphoma look nearly identical under the microscope — both appear as infiltration of small lymphocytes into the intestinal mucosa. Studies show that pathologists disagree on the diagnosis in a significant proportion of cases based on conventional staining alone. Furthermore, chronic inflammation (IBD) and lymphoma often occur together, and it has been proposed that IBD may in some cases progress to lymphoma — though there is not yet direct evidence of such transformation. These may not be two entirely separate diseases but rather a possible continuum.
Diagnosis Requires Advanced Methods
Ultrasound guides biopsy site selection but cannot alone differentiate IBD from lymphoma. Tissue sampling via endoscopy or surgical biopsy is essential. Histopathology alone (H&E staining) identifies lymphoma with only 60–75% sensitivity. Immunohistochemistry (CD3/CD20) identifies whether the cell population is T-cell or B-cell in origin — low-grade lymphoma is T-cell in origin in 80–95% of cases. PARR clonality testing (PCR) is a useful ancillary test that identifies whether the population is monoclonal (suggesting lymphoma) or polyclonal (inflammation). However, it is not used on its own, as its ability to distinguish inflammation from lymphoma is limited — especially in cats. The cornerstone of diagnosis is the combination of histopathology and immunohistochemistry, which PARR complements in ambiguous cases. Together they reach about 80–85% diagnostic accuracy.
Treatment and Prognosis
IBD is treated with dietary change (hydrolyzed protein) and immunosuppression (prednisolone, budesonide). The prognosis is generally good — most animals live for years with proper treatment. Low-grade lymphoma has a significantly better prognosis than high-grade: the response rate is 85–96%, and median survival is 1.5–2.5 years, with some animals surviving over 5 years. High-grade lymphoma has a more guarded prognosis (median survival 1.5–6 months).
Why Accurate Diagnosis Matters
If lymphoma is treated as IBD, corticosteroids may initially relieve symptoms and create a false sense of security. Adding immunosuppression (e.g., cyclosporine) can weaken anti-tumor immunity and accelerate lymphoma progression. Conversely, incorrectly treating IBD with chemotherapy exposes the animal to unnecessary side effects. We recommend advanced diagnostic testing in all equivocal cases — contact our clinic.
Sources
- Marsilio S. ym. (2023): ACVIM consensus statement guidelines on diagnosing and distinguishing low-grade neoplastic from inflammatory lymphocytic chronic enteropathies in cats. Journal of Veterinary Internal Medicine 37(3):794–816. ncbi.nlm.nih.gov
- Paulin M.V. ym. (2018): Feline low-grade alimentary lymphoma — an emerging entity and a potential animal model for human disease. BMC Veterinary Research 14:306. ncbi.nlm.nih.gov
- Pope K.V. ym. (2015): Outcome and toxicity assessment of feline small cell lymphoma — 56 cases. Veterinary Medicine and Science 1(2):51–62. ncbi.nlm.nih.gov
- Marsilio S. ym. (2019): Histopathology, immunohistochemistry and molecular clonality testing of small intestinal biopsy specimens from clinically healthy client-owned cats. Journal of Veterinary Internal Medicine 33(2):551–558. doi.org